Loading
Latest filing published 10 Jun 2019 for Zenicor Medical AB, €1,817.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
This profile gathers the share dealings of Gundars Rasmanis in Zenicor Medical AB. We count 4 filings; the first trade dates from 9 June 2017 and the latest from 7 June 2019.
In open-market terms, that means 3 purchases worth €8,702 on one side and 1 sale worth €2,252 on the other. Netting one side against the other leaves €6,450 of net buying. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. So far in 2019, the count stands at 1 purchase and no sales.
Half of the purchases are above €1,817 and half below.
The record was last updated on 10 June 2019 with an open-market purchase (€1,817) in Zenicor Medical AB. Filings reach the Finansinspektionen feed a median of 7 days after the trade. The legal deadline for notifying a trade is three business days (MAR article 19). This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations